Michael Karin

28PUBLICATIONS
164CO-AUTHORS
Cancer cell biologyFood properties (incl. characteristics and health benefits)Predictive and prognostic markersHaematological tumoursInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|Sep 22, 2026
Inflammatory memory inactivates AMPK-stimulated DDR1 degradation to enable pancreatic cancer growth.

|Aug 21, 2026
A multi-functional oral small molecule targeting energy and lipid metabolism to treat obesity and related metabolic disorders.

|Aug 11, 2026
Hepatocyte-intrinsic ER stress and NRF2 initiate primary sclerosing cholangitis, providing therapeutic insights.

|Feb 04, 2026
Activated ATF6α is a hepatic tumour driver restricting immunosurveillance.

Xin Li, Cynthia Lebeaupin, Aikaterini Kadianaki

|Jan 21, 2026
Selective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug.

Laura Antonucci, Kosuke Watari, Yechen Feng

|Oct 24, 2025
Obesity-related microbial dysbiosis as a potential modulator of tumour progression.

Omar Mokhashi, Jaideep Chakladar, Wei Tse Li

Pageof 5

Frequent Collaborators

9 joint publications

Kosuke Watari

4 joint publications

Li Gu

3 joint publications

Ludmil B Alexandrov

3 joint publications

Robert F Schwabe